Spots Global Cancer Trial Database for filanesib
Every month we try and update this database with for filanesib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | NCT01372540 | Plasma Cell Leu... Recurrent Plasm... Refractory Plas... | Carfilzomib Filanesib Laboratory Biom... | 18 Years - | M.D. Anderson Cancer Center | |
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients | NCT02384083 | Multiple Myelom... | Filanesib, poma... | 18 Years - | PETHEMA Foundation | |
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients | NCT02384083 | Multiple Myelom... | Filanesib, poma... | 18 Years - | PETHEMA Foundation | |
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | NCT01372540 | Plasma Cell Leu... Recurrent Plasm... Refractory Plas... | Carfilzomib Filanesib Laboratory Biom... | 18 Years - | M.D. Anderson Cancer Center |